SCHEMBL2150082

SCHEMBL2150082

Cc1ccc(N(c2ccc(C)cc2)c2cc(Cl)cc(Cl)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CNR2 P34972 5/20 0.37
▸ CNR1 P21554 4/20 0.37
▸ ACHE P22303 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CES2 O00748 1/20 0.34
▸ CES1 P23141 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ CTSL P07711 1/20 0.33
▸ CTSB P07858 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HCRTR2 O43614 1/20 0.33
▸ CHKA P35790 1/20 0.33
▸ MCOLN3 Q8TDD5 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ RAPGEF4 Q8WZA2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17780834 0.95 ALDH1A1 (0.42) TSHRALDH1A1CNR2CNR1ACHE
SCHEMBL22336635 0.88 ALDH1A1 (0.42) TSHRALDH1A1CNR2CNR1ACHE
SCHEMBL6353251 0.83 CES2 (0.48) TSHRALDH1A1CNR2CNR1ACHE
SCHEMBL8469732 0.83 CES2 (0.48) TSHRALDH1A1CNR2CNR1ACHE
SCHEMBL313428 0.83 ALDH1A1 (0.52) TSHRALDH1A1ACHETDP1KDM4E
SCHEMBL16318397 0.81 HTR3E (0.44) TSHRALDH1A1MAPTTP53HCRTR2
SCHEMBL615437 0.80 ALDH1A1 (0.61) TSHRALDH1A1ACHETDP1KDM4E
SCHEMBL16982395 0.80 ALDH1A1 (0.61) TSHRALDH1A1ACHETDP1KDM4E
SCHEMBL6123161 0.80 ALDH1A1 (0.61) TSHRALDH1A1ACHETDP1KDM4E
SCHEMBL12240222 0.80 ALDH1A1 (0.61) TSHRALDH1A1ACHETDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8029920-B2 1,3,5-tris(diarylamino)benzenes and use thereof BANDO CHEMICAL INDUSTRIES, LTD (JP) 2011-10-04 — — US disclosed
US-8029920-B2 1,3,5-tris(diarylamino)benzenes and use thereof BANDO CHEMICAL INDUSTRIES, LTD (JP) 2011-10-04 — — US disclosed
US-8029920-B2 1,3,5-tris(diarylamino)benzenes and use thereof BANDO CHEMICAL INDUSTRIES, LTD (JP) 2011-10-04 — — US disclosed
EP-1995235-B1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF BANDO CHEMICAL IND (JP) 2011-09-14 — — EP disclosed
EP-1995235-B1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF BANDO CHEMICAL IND (JP) 2011-09-14 — — EP disclosed
US-20110186834-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2011-08-04 — — US disclosed
US-20110186834-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2011-08-04 — — US disclosed
US-20110186834-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2011-08-04 — — US disclosed
EP-2341043-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF Bando Chemical Industries, Ltd. (JP) 2011-07-06 — — EP disclosed
EP-2341043-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF Bando Chemical Industries, Ltd. (JP) 2011-07-06 — — EP disclosed
US-20090058287-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2009-03-05 — — US disclosed
US-20090058287-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2009-03-05 — — US disclosed
US-20090058287-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2009-03-05 — — US disclosed
EP-1995235-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2008-11-26 — — EP disclosed
EP-1995235-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2008-11-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110186834-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENE AND USE THEREOF CBR1, CYP1B1, CBR3 TSHR 2233/4885ALDH1A1 418/4885CNR2 17/4885
US-20090058287-A1 NOVEL 1,3,5-TRIS(DIARYLAMINO)BENZENES AND USE THEREOF TMBIM6, TNPO1, CACNA1I TSHR 4439/4885ALDH1A1 2458/4885CNR2 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback